Skip Nav Destination
.Getting the Most from Minimal Residual Disease|
November 5, 2020
Use of Minimal Residual Disease and Advances in Clinical Trials
Davide Rossi, MD PhD
Davide Rossi, MD PhD
1Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Search for other works by this author on:
Blood (2020) 136 (Supplement 1): SCI1.
Citation
Davide Rossi; Use of Minimal Residual Disease and Advances in Clinical Trials. Blood 2020; 136 (Supplement 1): SCI1. doi: https://doi.org/10.1182/blood-2020-133037
Download citation file:
November 5 2020
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal